Interaction databaseSupplement × PrescriptionReviewed May 2026

Ginkgo Biloba and Ticagrelor, a caution.

Ginkgo biloba inhibits platelet-activating factor and platelet aggregation. Added to ticagrelor's reversible P2Y12 inhibition, the antiplatelet effect of ginkgo creates an additive bleeding risk, including the spontaneous intracranial and ocular bleeding reported in ginkgo case literature.

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances
Ginkgo Biloba and Ticagrelor
Pair type
Caution
Evidence (highest tier)
Moderate
Source citations
2 sources
Stack Score effect
−5 to your Stack Score (per scored caution row).
Scope
Supplement × Prescription
Last verified
May 30, 2026

Caution · Moderate evidence

Caution

What is happening. Ginkgo biloba inhibits platelet-activating factor and platelet aggregation. Added to ticagrelor's reversible P2Y12 inhibition, the antiplatelet effect of ginkgo creates an additive bleeding risk, including the spontaneous intracranial and ocular bleeding reported in ginkgo case literature.

Mechanism. Ginkgolides (notably ginkgolide B) are PAF antagonists that inhibit platelet aggregation. This pharmacodynamic effect is additive to ticagrelor's blockade of ADP-mediated platelet activation via P2Y12.

Recommendation. Avoid ginkgo biloba while on ticagrelor. If you have been combining them, stop the ginkgo and call your prescriber if you notice unusual bruising, nosebleeds, or any sign of bleeding.

Sources (2)
  1. Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. J Gen Intern Med. 2005;20(7):657-61. PMID 16050865
  2. Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy. 2011;31(5):490-502. PMID 21923430

Stack Score

How this pair moves the number.

Effect on the composite score

If both Ginkgo Biloba and Ticagrelor are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.